SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micromet Inc (MITI)
MITI 0.1200.0%11:29 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Arthur Radley9/17/2009 10:31:15 AM
   of 196
 
News Breaks
September 17, 2009
06:37 EDT MITI theflyonthewall.com: Micromet shares should remain strong for rest of year, says Merriman
Merriman expects Micromet shares to continue performing well for the remainder of the year due to meaningful clinical catalysts. The firm raised its target range on shares to $12-$13 from $7-$8 and reiterates a Buy rating. :theflyonthewall.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext